AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 46 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $12,000 | -29.4% | 20,000 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $17,000 | +30.8% | 20,000 | 0.0% | 0.00% | – |
Q2 2019 | $13,000 | -18.8% | 20,000 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $16,000 | -71.4% | 20,000 | -42.9% | 0.00% | -50.0% |
Q4 2018 | $56,000 | -43.4% | 35,000 | +16.7% | 0.00% | -50.0% |
Q3 2018 | $99,000 | +45.6% | 30,000 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $68,000 | +134.5% | 30,000 | +200.0% | 0.00% | +200.0% |
Q1 2018 | $29,000 | -90.6% | 10,000 | -90.9% | 0.00% | -90.9% |
Q4 2017 | $307,000 | -23.4% | 109,875 | 0.0% | 0.01% | -21.4% |
Q3 2017 | $401,000 | +64.3% | 109,875 | 0.0% | 0.01% | +75.0% |
Q2 2017 | $244,000 | +360.4% | 109,875 | +22.9% | 0.01% | +300.0% |
Q1 2017 | $53,000 | +10.4% | 89,375 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $48,000 | -57.5% | 89,375 | -29.9% | 0.00% | -50.0% |
Q3 2016 | $113,000 | -8.1% | 127,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $123,000 | +5.1% | 127,500 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $117,000 | -27.3% | 127,500 | 0.0% | 0.00% | -20.0% |
Q4 2015 | $161,000 | +4.5% | 127,500 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $154,000 | -30.6% | 127,500 | 0.0% | 0.01% | -16.7% |
Q2 2015 | $222,000 | +29.8% | 127,500 | +8.3% | 0.01% | +20.0% |
Q1 2015 | $171,000 | +72.7% | 117,700 | 0.0% | 0.01% | +66.7% |
Q4 2014 | $99,000 | -40.7% | 117,700 | -21.7% | 0.00% | -40.0% |
Q3 2014 | $167,000 | -39.3% | 150,400 | 0.0% | 0.01% | -37.5% |
Q2 2014 | $275,000 | +22.2% | 150,400 | 0.0% | 0.01% | +14.3% |
Q1 2014 | $225,000 | – | 150,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|